Intraosseous route of administration for delivering drugs has been
traditionally used to gain vascular access in patients suffering from
crtitical illness. Vascular access in patients suffering from
life-threatening conditions or in case of medical emergencies has
been essentially performed through intravenous access/route (IV),
which has been the cornerstone in the drug delivery, particularly
when high volume of medication is to be administered. However,
certain medical conditions make it difficult to establish an
efficient intravenous route, especially in conditions such as low
blood pressure or in pediatric cases. This could result in serious
conditions in patients suffering from chronic diseases. Hence, a
safer and faster route of administration such as intraosseous route
(IO) is required. This is performed by accessing the bone marrow
directly with the help of various access devices, which enable health
care providers to establish a quicker and more reliable vascular
access in patients for delivery of drugs.
The global intraosseous devices market is driven by increase in
incidence of trauma and accident cases across the world, presenting
large population requiring quick and reliable vascular access for
treatment of patients, rise in incidence of chronic diseases
including cancer, and new and advanced products and devices with
improved efficiency being introduced in the global market. New
automatic intraosseous devices such as PerSys Medical’s Bone
Injection Gun (BIG) and Teleflex Incorporated’s EZ-IO are the
recently introduced devices in the intraosseous devices market.
These are gaining increasing adoption and acceptance by health care
providers which is expected to drive the global market from 2017 to
2025. However, lack of awareness among general population and health
care providers in emerging countries about the new and advanced
intraosseous devices along with persistent preference for IV route
are expected to restrain the global intraosseous devices market
during the forecast period.
The global intraosseous devices market can be segmented based on
device type, end-user, and region. In terms of device type, the
global market can be categorized into manual intraosseous devices,
semi-automatic intraosseous devices, and automatic intraosseous
devices. The semi-automatic intraosseous devices segment is expected
to dominate the global market in 2017 because of higher preference of
health care providers for these devices due to lower health care
associated costs and new and advanced product introductions by market
players in this segment. However, the automatic intraosseous devices
segment in expected to register comparatively higher CAGR during the
forecast period, due to distinct advantages over semi-automatic
devices.
Download Report Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=37775
Based on end-user, the global intraosseous devices market can be
classified into hospitals, ambulatory care centers, specialty
clinics, urgent care centers, and others. The urgent care centers
segment is expected to expand at a high CAGR owing to increase in
traumatic surgeries being performed in these settings in emerging
countries such as Brazil, China, and India. The hospitals segment is
expected to dominate the global intraosseous devices market from 2017
to 2025. This is attributed to large patient population suffering
from chronic diseases being treated in hospital settings in Asia
Pacific, Latin America, and Middle East & Africa.
In terms of region, the global intraosseous devices market can be
segmented into North America, Europe, Asia Pacific, Latin America,
and Middle East & Africa. North America dominated the global
market in 2016 due to greater adoption and consumption of
intraosseous devices, higher incidence of trauma and accident
injuries in the U.S., and significant preference for intraosseous
route in the region. Europe accounted for the second largest share,
followed by Asia Pacific, of the global market in 2016.
Key players operating in the global intraosseous devices market are
Teleflex Incorporated, PerSys Medical, Cook Medical, Becton,
Dickinson and Company, and Medical Dynamics, Inc.
Pre-Book Full Report @
https://www.transparencymarketresearch.com/checkout.php?rep_id=37775<ype=S
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment